Chronotherapy in Nigerian hypertensives

Therapeutic Advances in Cardiovascular Disease

Volumn 5, Issue 2, 2011, Pages 113-118

  Okeahialam, Basil ^a   Ohihoin, Esther ^a   Ajuluchukwu, Jayne ^a  

^a LAGOS UNIVERSITY TEACHING HOSPITAL   (Nigeria)

Author keywords

Blacks; Chronotherapy; Hypertension; Night time; Successful

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; THIAZIDE DIURETIC AGENT;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR PARAMETERS; CHRONOTHERAPY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE SEPTUM; HUMAN; HYPERTENSION; LEFT VENTRICULAR POSTERIOR DIAMETER; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORBIDITY; MORTALITY; NIGERIA; OUTPATIENT CARE; PRIORITY JOURNAL; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPHYGMOMANOMETRY; SYSTOLIC BLOOD PRESSURE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CHI-SQUARE DISTRIBUTION; DRUG CHRONOTHERAPY; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; NIGERIA; TREATMENT OUTCOME;

EID: 79955998951     PISSN: 17539447     EISSN: 17539455     Source Type: Journal    
DOI: 10.1177/1753944711402119     Document Type: Article

References (25)

1. Adeyemo A.A. Omotade O.O. Rotimi C.N. Luke A.H. Tayo B.O. Cooper R.S. (2002) Heritability of blood pressure in Nigerian families. J Hypertens 20: 859–863.
2. Araoye M.A. (1996) Left ventricular hypertrophy by electrocardiography: A code system applicable to Negroes. Nig Postgrad Med J 3: 92–97.
3. Brotman D.J. Davidson M.B. Boumitri M. Vidt D.G. (2008) Impaired diurnal blood pressure variation and all cause mortality. Am J Hypertens 21: 92–97.
4. Chobanian A.V. Bakris G.L. Black H.R. Cushman W.C. Green L.A. Izzo J.L. Jr et al (2003) The 7th report of Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure - The JNC 7 Report. Hypertension 42: 1206–1252.
5. Elliot W.J. (1998) Circadian variation in the timing of stroke onset. Stroke 29: 992–996.
6. Hermida R.C. Ayala D.E. (2009) Chronotherapy with angiogenesin converting enzyme inhibitor, Ramipril in essential hypertension. Improved blood pressure control with bed time dosing. Hypertension 54: 40–46.
7. Hermida R.C., Ayala D.E., Calvo C. (2005) Administration time dependent effects of anti-hypertensive treatment on the circadian pattern of blood pressure. Curr Opin Nephrol Hypertens 14: 453–459.
8. Hermida R.C. Ayala D.E. Calvo C. (2007 a) Optimal timing for anti-hypertensive dosing: focus on Valsartan. Ther Clin Risk Manag 3: 119–131.
9. Hermida R.C. Ayala D.C. Calvo C. Portaluppi F. Smolensky M.H. (2007 b) Chronotherapy of hypertension: administration time dependent effects of treatment on the circadian pattern of blood pressure. Adv Drug Deliv Rev 59: 923–939.
10. Hermida R.C. Ayala D.E. Mojon A. Fernandez J.R. (2008) Chronotherapy with Nifedipine GITS in hypertensive patients. Improved efficacy and safety with bedtime dosing. Am J Hypertens 21: 948–954.
11. Hermida R.C. Smolensky M.H. (2004) Chronotherapy of hypertension. Curr Opin Nephrol Hypertens 13: 501–505.
12. Ikeda T. Gomi T. Shibuya Y. Suzuki Y. Matsuda N. (2007) Add on effect of bedtime dosing of alpha 1 adrenergic receptor antagonist doxazosin on morning hypertension and left ventricular hypertrophy I patients undergoing long term amlodipine immunotherapy. Hypertens Res 30: 1011–1013.
13. Kannel W.B. (1995) Coronary risk factors: an overview. In: Ed. Wilkerson J.N. Cohn J.N. (eds) Cardiovascular Medicine. Churchill Livingstone: New York.
14. Kario K. Schwartz J.E. Pickering T.G. (2000) Changes of nocturnal blood pressure dipping status in hypertensives by night time dosing of alpha adrenergic blocker doxazosin. Result from the HALT study. Hypertension 35: 787–794.
15. Kikuya M. Ohkubo T. Asayama K. Metoki H. Obura T. Saito S. et al (2005) Ambulatory blood pressure and 10 year risk of cardiovascular and non-cardiovascular mortality: the Ohasama study. Hypertension 45: 240–245.
16. Koopman M.G. Koomen G.C. Kredeit R.T. de Moor E.A. Hoek F.J. Arisz L. (1989) Circadian rhythm of glomerular filtration rate in normal individuals. Clin Sci (Lond) 77: 105–111.
17. Labrecque G. Beauchamp D. (2003) Rhythms and pharmacokinetics. In: Ed. Redfern P. (ed.) Chronotherapeutics. Pharmaceutical Press: London.
18. Minutolo R. Gabbai F. Borrelli S. Scigliano R. Trucillo P. Baldanza D. et al (2007) Changing the timing of anti-hypertensive therapy to reduce nocturnal blood pressure in chronic kidney disease: An 8 week uncontrolled trial. Am J Kidney Dis 50: 908–917.
19. Morgan T.O. Anderson A. (2003) Different drug classes have variable effects on blood pressure depending on the time of day. Am J Hypertens 16: 46–50.
20. Morgan T.O. Brunner H.R. Aubert J.F. Wang Q. Grffiths C. Delbridge L. (2000) Cardiac hypertrophy depends upon sleep blood pressure: a study in rats. J Hypertens 18: 445–451.
21. Sacks F.M. Svetkey L.P. Vollmer W.M. Appel L.J. Bray G.A. Harsha D. et al (2001) Effect on blood pressure of reduced dietary sodium and dietary approaches to stop hypertension (DASH) diet. N Engl J Med 344: 3–10.
22. Sahn D.J. de Maria A. Kislo J. Weyman A. (1978) Recommendations regarding quantification in M mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58: 1072–1083.
23. Turnbull F. for the Blood Pressure Lowering Treatment Trialists Collaboration. (2003) Effects of different blood pressure lowering regimens on major cardiovascular events: results of prospectively designed over views of randomized trials. Lancet 362: 1527–1535.
24. WHO. (2002) The World Health Report 2002. Reducing risks and promoting health life. World Health Organization: Geneva.
25. Williams G.H. (2001) Hypertensive vascular disease. In: Ed. Braun Wald E. (ed.) Harrisson's Principles of Internal Medicine McGraw-Hill: New York.